Jump to content

Virbac

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Fabsss (talk | contribs) at 11:31, 26 August 2024. The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Virbac
Company typeS.A. (corporation)
EuronextVIRP
SBF 120
ISINFR0000031577 Edit this on Wikidata
IndustryAnimal Health Care
Founded1968
FounderPierre-Richard Dick
Headquarters,
Number of locations
35 subsidiaries
Area served
More than 100 countries
ProductsAntibiotics, vaccines, dermatology, antiparasitics, dental hygiene...
RevenueIncrease 1,247 M (2023)
Number of employees
5,500 (2023)
Websitecorporate.virbac.com

Virbac is a French company dedicated to animal health located in Carros, near Nice. It was founded in 1968 by veterinarian Pierre-Richard Dick.

The company is the 6th[1] the largest veterinarian pharmaceutical group with a turnover of 1,247 million euros in 2023 (59% companion animal and 41% food producing animal). The company is a limited company with a board Euronext Paris stock exchange - compartiment A and is part of the reference index: SBF 120, and eligible SRD, PEA and PEA-PME.

History

[edit]

Veterinarians Pierre-Richard Dick and Max Rombi founded Virbac (acronym of virology and bacteriology) in 1968.[2]

Activities

[edit]

The company has 5,500 employees and is now present in over 100 countries with 35 sales subsidiaries. Its production is located in 10 countries among which France, the US, Mexico, Brazil, Vietnam. It also has eight research and development centers located in the United States, Mexico, Chile, Uruguay, France, Vietnam, Taiwan and Australia.[3] It generates nearly 72% of its revenues outside France.

Its product range is designed to cover the main pathologies in companion animals and livestock: internal and external parasiticides (collars and pipettes), antibiotics, vaccines, diagnostic tests, dog and cat nutrition, dermatology, dental hygiene, reproductive, aquaculture, anesthesia, geriatrics and electronic identification (pets, horses, exotic pets…).

References

[edit]
  1. ^ "Animal health: Virbac announces 2-digits growth for 2012". 12 March 2013. Retrieved 29 December 2015.
  2. ^ Bloch, Alain; Joseph, Alexandra; Santi, Michel (2010). "Propelled into the future: managing family firm entrepreneurial growth despite generational breakthroughs within family life stage". Transgenerational Entrepreneurship: Exploring Growth and Performance in Family Firms Across Generations. Edward Elgar Publishing. pp. 144–147. ISBN 978-1-84980-546-9.
  3. ^ "Key figures 2014". Virbac. Retrieved 29 December 2015.
[edit]